151 related articles for article (PubMed ID: 28352058)
1. The relationship between anti-C-reactive protein and disease activity in patients with systemic lupus erythematosus.
Son CN; Lee TH; Bang JH; Jeong HJ; Chae JN; Lee WM; Kim JM; Kim SH
Korean J Intern Med; 2018 Jul; 33(4):823-828. PubMed ID: 28352058
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus.
Jung JY; Koh BR; Kim HA; Jeon JY; Suh CH
J Investig Med; 2014 Aug; 62(6):890-3. PubMed ID: 24896736
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
[TBL] [Abstract][Full Text] [Related]
4. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T
Arthritis Res Ther; 2004; 6(2):R87-94. PubMed ID: 15059271
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels.
Delongui F; Lozovoy MAB; Iriyoda TMV; Costa NT; Stadtlober NP; Alfieri DF; Flauzino T; Dichi I; Simão ANC; Reiche EMV
Clin Rheumatol; 2017 Aug; 36(8):1779-1788. PubMed ID: 28567557
[TBL] [Abstract][Full Text] [Related]
8. Studies of serum C-reactive protein in systemic lupus erythematosus.
Williams RC; Harmon ME; Burlingame R; Du Clos TW
J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
[TBL] [Abstract][Full Text] [Related]
9. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
10. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
[TBL] [Abstract][Full Text] [Related]
11. [Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus].
Padjas A; Undas A; Swadzba J; Musiał J
Pol Arch Med Wewn; 2007 Mar; 117(3):20-5. PubMed ID: 17718048
[TBL] [Abstract][Full Text] [Related]
12. Elevation of serum ferritin levels as a marker for active systemic lupus erythematosus.
Nishiya K; Hashimoto K
Clin Exp Rheumatol; 1997; 15(1):39-44. PubMed ID: 9093771
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
O'Neill SG; Giles I; Lambrianides A; Manson J; D'Cruz D; Schrieber L; March LM; Latchman DS; Isenberg DA; Rahman A
Arthritis Rheum; 2010 Mar; 62(3):845-54. PubMed ID: 20131231
[TBL] [Abstract][Full Text] [Related]
14. Serum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus.
Chew C; Pemberton PW; Husain AA; Haque S; Bruce IN
Clin Exp Rheumatol; 2013; 31(2):251-5. PubMed ID: 23306163
[TBL] [Abstract][Full Text] [Related]
15. Platelet-to-lymphocyte ratio as a biomarker of systemic inflammation in systemic lupus erythematosus: A meta-analysis and systematic review.
Lee YH; Song GG
PLoS One; 2024; 19(5):e0303665. PubMed ID: 38753735
[TBL] [Abstract][Full Text] [Related]
16. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus.
Chun HY; Chung JW; Kim HA; Yun JM; Jeon JY; Ye YM; Kim SH; Park HS; Suh CH
J Clin Immunol; 2007 Sep; 27(5):461-6. PubMed ID: 17587156
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of Thyroid Autoantibodies,System Lupus Erythematosus Immunologic Indicators and Disease Activity in SLE with HT].
Liu H; Yang LH; Yin G; Xie QB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):179-182. PubMed ID: 29737056
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
Li YN; Hu FL; Dai YJ; Li R; Ma XX; Du Y; Feng M; Jia Y; Zhang CF; Zhu L; Ascherman DP; Li ZG
Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
